{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T04:24:29Z","timestamp":1744345469215,"version":"3.40.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.trre.2025.100914","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T16:18:57Z","timestamp":1741537137000},"page":"100914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing cumulative exposure to maintenance immunosuppressive drugs: Metrics, outcomes, and implications for transplant patients"],"prefix":"10.1016","volume":"39","author":[{"given":"Cavizshajan","family":"Skanthan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakindu","family":"Somaweera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhumitha","family":"Rabindranath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani","family":"Orchanian-Cheff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Viau-Trudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusegun","family":"Famure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2025.100914_bb0005","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1177\/0962280220902179","article-title":"Modeling of cumulative effects of time-varying drug exposures on within-subject changes in a continuous outcome","volume":"29","author":"Danieli","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.trre.2025.100914_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jclinepi.2015.05.026","article-title":"Measuring drug exposure: concordance between defined daily dose and days\u2019 supply depended on drug class","volume":"69","author":"Sinnott","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.trre.2025.100914_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","article-title":"The impact of Oral corticosteroid use on bone mineral density and vertebral fracture","volume":"166","author":"Walsh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2025.100914_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew457","article-title":"Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case\u2013control study","author":"Hsu","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.trre.2025.100914_bb0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/cc.7.4.5454","article-title":"Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy","volume":"7","author":"Zeiser","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trre.2025.100914_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0035","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2025.100914_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-0012.2004.00298.x","article-title":"Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies","volume":"19","author":"Anil Kumar","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2025.100914_bb0045","doi-asserted-by":"crossref","first-page":"III-222","DOI":"10.1161\/circ.102.suppl_3.III-222","article-title":"Skin Cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy","volume":"102","author":"Caforio","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2025.100914_bb0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.transproceed.2005.02.055","article-title":"High initial blood levels of tacrolimus in overweight renal transplant recipients","volume":"37","author":"Rodrigo","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2025.100914_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1399-0012.1992.tb00619.x","article-title":"Impact of chronic corticosteroid administration on intraocular pressure in renal transplant recipients","volume":"6","author":"Perell","year":"1992","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2025.100914_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/ndt\/gfac044","article-title":"Adrenal insufficiency is common amongst kidney transplant recipients receiving maintenance prednisolone and can be predicted using morning cortisol","volume":"38","author":"Tomkins","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0065","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.2021081081","article-title":"Natural history of bone disease following kidney transplantation","volume":"33","author":"J\u00f8rgensen","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2025.100914_bb0070","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1097\/TP.0000000000002760","article-title":"Area under trough concentrations of tacrolimus as a predictor of progressive renal impairment after liver transplantation","volume":"103","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100914_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1526924816640980","article-title":"Restless legs syndrome following lung transplantation: prevalence and relationship with tacrolimus exposure","volume":"26","author":"Menninga","year":"2016","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1526924817699960","article-title":"Insomnia and relationship with immunosuppressant therapy after lung transplantation","volume":"27","author":"Rohde","year":"2017","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trim.2018.06.005","article-title":"Tacrolimus has immunosuppressive effects on heavy\/light chain pairs and free light chains in patients after heart transplantation: a relationship with infection","volume":"50","author":"Lavr\u00edkov\u00e1","year":"2018","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2025.100914_bb0090","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/TP.0000000000003384","article-title":"Evaluation of longitudinal exposure to tacrolimus as a risk factor of chronic kidney disease occurrence within the first-year post-liver transplantation","volume":"105","author":"Maurel","year":"2021","journal-title":"Transplantation"},{"author":"Sinclair","key":"10.1016\/j.trre.2025.100914_bb0095"},{"key":"10.1016\/j.trre.2025.100914_bb0100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfy306","article-title":"Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol","volume":"35","author":"Evenepoel","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0105","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.transproceed.2004.05.053","article-title":"Does the endothelial function change in renal transplant patients with longer duration of exposure and with higher cumulative doses of cyclosporine?","volume":"36","author":"Mercanoglu","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2025.100914_bb0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007890-199608150-00011","article-title":"Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine","volume":"62","author":"Falkenhain","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2025.100914_bb0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1053-2498(99)00013-3","article-title":"Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation","volume":"18","author":"Cook","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0120","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1359\/jbmr.1999.14.11.1943","article-title":"Cross-sectional analysis of renal transplantation osteoporosis","volume":"14","author":"Parker","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.trre.2025.100914_bb0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-9343(88)80234-1","article-title":"Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients","volume":"85","author":"Becker","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.trre.2025.100914_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3350\/cmh.2014.20.2.192","article-title":"Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation","volume":"20","author":"Lee","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.trre.2025.100914_bb0135","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/ijc.34875","article-title":"Immunosuppression and cancer risk in kidney transplant recipients: a retrospective cohort study","volume":"154","author":"Sapir-Pichhadze","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2025.100914_bb0140","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1111\/ajt.17021","article-title":"Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation","volume":"22","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111461","article-title":"Adequate cumulative exposure to tacrolimus and low tacrolimus variability decrease the incidence of biliary complications after liver transplantation","volume":"128","author":"Pan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trre.2025.100914_bb0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2013.03.009","article-title":"Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach","volume":"72","author":"Daher Abdi","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trre.2025.100914_bb0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00228-017-2234-2","article-title":"The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation","volume":"73","author":"Lichtenberg","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.trre.2025.100914_bb0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/lt.20391","article-title":"Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression","volume":"11","author":"Vivarelli","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2025.100914_bb0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00365521.2021.2010799","article-title":"Reduced calcineurin inhibitor exposure with antibody induction and recurrent hepatocellular carcinoma after liver transplantation","volume":"57","author":"Abrahamsson","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trre.2025.100914_bb0170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/jcm10081558","article-title":"Effect of mycophenolate Mofetil therapy on recurrence of hepatocellular carcinoma after liver transplantation: a population-based cohort study","volume":"10","author":"Tsai","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.trre.2025.100914_bb0175","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5864","article-title":"Cancer and mTOR inhibitors in kidney transplantation recipients","volume":"6","author":"Kao","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.trre.2025.100914_bb0180","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.140.9.1079","article-title":"Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients","volume":"140","author":"Fortina","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.trre.2025.100914_bb0185","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/tri.14012","article-title":"Malignancy among adult heart transplant recipients following patient-tailored dosing of anti-thymocyte globulin: a retrospective, nested case-control study of individualized dosing","volume":"34","author":"Bubik","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2025.100914_bb0190","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/FTD.0000000000001035","article-title":"Longitudinal exposure to tacrolimus and new-onset diabetes mellitus in renal transplant patients","volume":"45","author":"Destere","year":"2023","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2025.100914_bb0195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive Medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2025.100914_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","article-title":"Immunosuppressive drugs: the first 50 years and a glance forward","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trre.2025.100914_bb0205","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Eckardt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2025.100914_bb0210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0897190003259838","article-title":"Corticosteroids in solid organ transplantation: update and review of the literature","volume":"16","author":"Smith","year":"2003","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.trre.2025.100914_bb0215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1681\/ASN.V94677","article-title":"Analysis of fracture prevalence in kidney-pancreas allograft recipients","volume":"9","author":"Chiu","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2025.100914_bb0220","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.trre.2025.100914_bb0225","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1148\/rg.2016150175","article-title":"Malignancy after solid organ transplantation: comprehensive imaging review","volume":"36","author":"Katabathina","year":"2016","journal-title":"RadioGraphics"},{"key":"10.1016\/j.trre.2025.100914_bb0230","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/TP.0000000000002414","article-title":"Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study","volume":"103","author":"H\u00f6cker","year":"2019","journal-title":"Transplantation"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2500014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2500014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T22:56:07Z","timestamp":1744325767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X2500014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0955470X2500014X"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2025.100914","relation":{},"ISSN":["0955-470X"],"issn-type":[{"type":"print","value":"0955-470X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing cumulative exposure to maintenance immunosuppressive drugs: Metrics, outcomes, and implications for transplant patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2025.100914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100914"}}